VENETOCLAX‐OBINUTUZUMAB MODULATES CLONAL GROWTH: RESULTS OF A POPULATION‐BASED MINIMAL RESIDUAL DISEASE MODEL FROM THE RANDOMIZED CLL14 STUDY

Weiterentwicklungen in der Molekulardiagnostik ermöglichen zuverlässigere Aussagen zur Differenzialdiagnostik maligner Erkrankungen. Sie sind Meilensteine für eine individualisierte Therapie. Darüber hinaus zeigt sich ihre zunehmende Bedeutung für prognostische Einschätzungen. Die Kontrolle der minimalen Resterkrankung (Minimal Residual Disease; MRD) rückt zunehmend in den Fokus, auch wenn noch viele Fragen zu klären sind.

Download Full-text

A mathematical approach to data evaluation with focus on prediction of minimal residual disease in pediatric ALL

Klinische Pädiatrie ◽

10.1055/s-0032-1310472 ◽

2012 ◽

Vol 224 (03) ◽

Author(s):

A Torge ◽

M Zimmermann ◽

A Möricke ◽

R Köhler ◽

A Schrauder ◽

...

Keyword(s):

Minimal Residual Disease ◽

Residual Disease ◽

Data Evaluation ◽

Mathematical Approach ◽

Pediatric All ◽

Minimal Residual

Download Full-text

Improving Diagnostic Methods for Minimal Residual Disease Detection (MRD) in Childhood Acute Lymphoblastic Leukemia (ALL)

Klinische Pädiatrie ◽

10.1055/s-0034-1374837 ◽

2014 ◽

Vol 226 (03) ◽

Author(s):

A Szymansky ◽

S Groeneveld-Krentz ◽

J Hof ◽

R Kirschner-Schwabe ◽

C Eckert

Keyword(s):

Acute Lymphoblastic Leukemia ◽

Minimal Residual Disease ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Diagnostic Methods ◽

Childhood Acute Lymphoblastic Leukemia ◽

Disease Detection ◽

Minimal Residual Disease Detection ◽

Minimal Residual

Download Full-text

VENETOCLAX‐OBINUTUZUMAB MODULATES CLONAL GROWTH: RESULTS OF A POPULATION‐BASED MINIMAL RESIDUAL DISEASE MODEL FROM THE RANDOMIZED CLL14 STUDY

Population-based study of the pattern of molecular markers of minimal residual disease in childhood and adult acute lymphoblastic leukemia: An assessment of the practical difficulty of representative sampling for trial purposes

A novel minimal residual disease model of neuroblastoma in mice

Abstract A05: A novel minimal residual disease model of neuroblastoma in mice

Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002â2006

Development of a Minimal Residual Disease Model for Ovarian Cancer Using Bioluminescence in an Immunocompetent Mouse Model

Decision letter for "MINIMAL RESIDUAL DISEASE (MRD) IN NON‐HODGKIN LYMPHOMAS: INTER‐LABORATORY REPRODUCIBILITY ON MARROW SAMPLES WITH VERY LOW LEVELS OF DISEASE WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK"

Review for "MINIMAL RESIDUAL DISEASE (MRD) IN NON‐HODGKIN LYMPHOMAS: INTER‐LABORATORY REPRODUCIBILITY ON MARROW SAMPLES WITH VERY LOW LEVELS OF DISEASE WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK"

ACUTE LEUKEMIAS 2019: Risikofaktor MRD eröffnet neue Perspektiven

A mathematical approach to data evaluation with focus on prediction of minimal residual disease in pediatric ALL

Improving Diagnostic Methods for Minimal Residual Disease Detection (MRD) in Childhood Acute Lymphoblastic Leukemia (ALL)

Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002â2006